Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

Ministry of Health, Malaysia8 个研究点分布在 1 个国家目标入组 1,600 人开始时间: 2010年8月最近更新: 2011年3月7日

适应症

试验速览

阶段: 不适用
发起方: Ministry of Health, Malaysia
入组人数: 1,600
试验地点: 8

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

研究设计

研究类型: Observational
时间视角: Cross Sectional

入排标准

年龄范围: 21 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 是

入选标准

•Patients of at least 21 years old on day of giving consent for study
•Patients must be able and wiling to give an informed consent
•Patient with chronic HBV infection
•Patient with active hepatocellular carcinoma and chronic hepatitis B
•Healthy subjects

排除标准

•Patients who have co-infection with HIV or chronic hepatitis C
•Subjects with other types of cancer

研究者

发起方

Ministry of Health, Malaysia

申办方类型

Other Gov

研究点 (8)

Loading locations...

相似试验

已完成

3 期

Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected PatientsHIV Infections

NCT00480792ANRS, Emerging Infectious Diseases437

已完成

2 期

A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination CoursesHIVCommunicable DiseasesHBVInfectious DiseasesHepatitis B

NCT02434848Sheffield Teaching Hospitals NHS Foundation Trust13

尚未招募

不适用

Prospective Cohort Study on Prognosis of Patients With Hepatitis B/CHepatitis CHepatitis B

NCT05102838Sun Yat-sen University60,000

已完成

不适用

Hepatitis B Virus Reactivation: a Cautionary Event After Liver Transplantation for Patients With Hepatocellular CarcinomaLiver Transplant Complications

NCT06114251Zhejiang University920

已完成

1 期

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B PatientsHepatitis B Virus (HBV)

NCT04168333Tasly Tianjin Biopharmaceutical Co., Ltd.36